CN104800167A - 一种氟苯尼考可溶性粉及其制备方法 - Google Patents
一种氟苯尼考可溶性粉及其制备方法 Download PDFInfo
- Publication number
- CN104800167A CN104800167A CN201510192169.6A CN201510192169A CN104800167A CN 104800167 A CN104800167 A CN 104800167A CN 201510192169 A CN201510192169 A CN 201510192169A CN 104800167 A CN104800167 A CN 104800167A
- Authority
- CN
- China
- Prior art keywords
- parts
- florfenicol
- soluble powder
- polyethylene glycol
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 title claims abstract description 78
- 229960003760 florfenicol Drugs 0.000 title claims abstract description 78
- 239000000843 powder Substances 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 28
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 24
- 239000008101 lactose Substances 0.000 claims abstract description 24
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 23
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 239000011973 solid acid Substances 0.000 claims abstract description 15
- 235000019441 ethanol Nutrition 0.000 claims abstract description 14
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 239000002671 adjuvant Substances 0.000 claims description 13
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- 239000001530 fumaric acid Substances 0.000 claims description 10
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 10
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 10
- 238000010790 dilution Methods 0.000 claims description 9
- 239000012895 dilution Substances 0.000 claims description 9
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- 229960001031 glucose Drugs 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 40
- 238000000034 method Methods 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000010992 reflux Methods 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 229940079593 drug Drugs 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 230000032683 aging Effects 0.000 description 8
- 238000010171 animal model Methods 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical class ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229940097572 chloromycetin Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 229960003053 thiamphenicol Drugs 0.000 description 4
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000009781 safety test method Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000012353 Contagious Pleuropneumonia Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000605008 Spirillum Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000001153 fluoro group Chemical class F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000005338 heat storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | 死亡/只 | 无效/只 | 转归/只 | 痊愈/只 | 转归率/% | 痊愈率/% |
第一组 | 2 | 2 | 3 | 3 | 30 | 30 |
第二组 | 0 | 2 | 4 | 4 | 40 | 40 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510192169.6A CN104800167B (zh) | 2015-04-22 | 2015-04-22 | 一种氟苯尼考可溶性粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510192169.6A CN104800167B (zh) | 2015-04-22 | 2015-04-22 | 一种氟苯尼考可溶性粉及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104800167A true CN104800167A (zh) | 2015-07-29 |
CN104800167B CN104800167B (zh) | 2018-04-10 |
Family
ID=53685667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510192169.6A Active CN104800167B (zh) | 2015-04-22 | 2015-04-22 | 一种氟苯尼考可溶性粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104800167B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105902497A (zh) * | 2016-06-01 | 2016-08-31 | 洛阳瑞华动物保健品有限公司 | 一种水溶性氟苯尼考兽药制剂的制备方法 |
CN106344516A (zh) * | 2016-10-17 | 2017-01-25 | 安庆市柯旷动物药业有限公司 | 一种氟苯尼考粉 |
CN107157974A (zh) * | 2017-06-12 | 2017-09-15 | 南京大方生物工程有限公司 | 一种氟苯尼考粉散剂及其制备方法 |
CN110302163A (zh) * | 2019-07-23 | 2019-10-08 | 东莞正大康地饲料有限公司 | 一种氟苯尼考可溶性粉及其制备方法 |
CN113679672A (zh) * | 2021-09-17 | 2021-11-23 | 江西成必信生物科技有限公司 | 一种高水溶性阿莫西林可溶性粉的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008133901A1 (en) * | 2007-04-27 | 2008-11-06 | Schering-Plough Ltd. | Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
CN101406456A (zh) * | 2007-10-12 | 2009-04-15 | 河南农业大学 | 氟苯尼考可溶性粉制备工艺 |
CN102697730A (zh) * | 2012-05-07 | 2012-10-03 | 郑州后羿制药有限公司 | 一种氟苯尼考可溶性粉及其制备方法 |
CN103550163A (zh) * | 2013-11-22 | 2014-02-05 | 青岛农业大学 | 一种兽用可溶性粉剂的辅料及其制备方法 |
CN104055727A (zh) * | 2014-06-19 | 2014-09-24 | 马改云 | 一种氟苯尼考固体分散体及其制备方法 |
-
2015
- 2015-04-22 CN CN201510192169.6A patent/CN104800167B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008133901A1 (en) * | 2007-04-27 | 2008-11-06 | Schering-Plough Ltd. | Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
CN101406456A (zh) * | 2007-10-12 | 2009-04-15 | 河南农业大学 | 氟苯尼考可溶性粉制备工艺 |
CN102697730A (zh) * | 2012-05-07 | 2012-10-03 | 郑州后羿制药有限公司 | 一种氟苯尼考可溶性粉及其制备方法 |
CN103550163A (zh) * | 2013-11-22 | 2014-02-05 | 青岛农业大学 | 一种兽用可溶性粉剂的辅料及其制备方法 |
CN104055727A (zh) * | 2014-06-19 | 2014-09-24 | 马改云 | 一种氟苯尼考固体分散体及其制备方法 |
Non-Patent Citations (2)
Title |
---|
SUYING MA ET AL.: ""Preparation and Characterization of Florfenicol-Polyethyleneglycol 4000 Solid Dispersions with Improved Solubility"", 《ASIAN JOURNAL OF CHEMISTRY》 * |
王淑华: ""泡腾片的常用辅料及制备方法"", 《食品与药品》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105902497A (zh) * | 2016-06-01 | 2016-08-31 | 洛阳瑞华动物保健品有限公司 | 一种水溶性氟苯尼考兽药制剂的制备方法 |
CN105902497B (zh) * | 2016-06-01 | 2019-06-11 | 洛阳瑞华动物保健品有限公司 | 一种水溶性氟苯尼考兽药制剂的制备方法 |
CN106344516A (zh) * | 2016-10-17 | 2017-01-25 | 安庆市柯旷动物药业有限公司 | 一种氟苯尼考粉 |
CN107157974A (zh) * | 2017-06-12 | 2017-09-15 | 南京大方生物工程有限公司 | 一种氟苯尼考粉散剂及其制备方法 |
CN110302163A (zh) * | 2019-07-23 | 2019-10-08 | 东莞正大康地饲料有限公司 | 一种氟苯尼考可溶性粉及其制备方法 |
CN113679672A (zh) * | 2021-09-17 | 2021-11-23 | 江西成必信生物科技有限公司 | 一种高水溶性阿莫西林可溶性粉的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104800167B (zh) | 2018-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104800167A (zh) | 一种氟苯尼考可溶性粉及其制备方法 | |
ES2591041T3 (es) | Uso de EDTA y sus sales para la prevención y tratamiento de enfermedades intestinales bacterianas en cerdos | |
CN101810569B (zh) | 一种恩诺沙星注射液及其制备方法 | |
CN101496811B (zh) | 一种可溶且稳定的替米考星组合物 | |
CN101822688B (zh) | 兽用复方泰乐菌素注射液及其制备方法 | |
CN105267142B (zh) | 一种恩诺沙星注射液及其制备方法 | |
CN103494832B (zh) | 一种兽用复方伊维菌素阿苯达唑透皮剂及其使用方法 | |
Arthington | New concepts in trace mineral supplementation of grazing cattle hydroxy sources, injectable sources and pasture application | |
CN102920655A (zh) | 氟苯尼考混悬注射液及其制备工艺 | |
CN102228462A (zh) | 兽用土青注射液制备方法及临床应用 | |
CN105616485A (zh) | 一种盐酸多西环素、牛至油组合物 | |
CN108670956A (zh) | 一种阿莫西林可溶性粉及其制备方法 | |
CN106620668A (zh) | 一种复方替米考星固体分散剂及其制备方法 | |
CN103211818B (zh) | 一种治疗或预防家畜细菌性和支原体疾病的药物组合物及其用途 | |
EP3288391A1 (en) | Feed supplement additive | |
CN102429918A (zh) | 一种含有氟苯尼考和茶皂素的药物组合物及其制备方法 | |
CN102614294A (zh) | 一种复方阿莫西林混悬注射剂及其制备方法 | |
AU2015100768A4 (en) | Development of Doxycycline Injectable for Caged and Aviary Birds and there of | |
CN101301274B (zh) | 兽用复方乙酰甲喹可溶性粉及其制备方法 | |
CN103169652A (zh) | 一种兽用碱性林可霉素注射液及其制备方法和用途 | |
EP3733176B1 (en) | Composition comprising piperacillin, pharmaceutical preparation thereof and use thereof | |
CN102973496B (zh) | 一种治疗家禽球虫病的地克珠利口服液的制备方法 | |
CN102755342B (zh) | 复方对乙酰氨基酚注射液及其制备方法 | |
CN101966201A (zh) | 复方烟酸诺氟沙星可溶性粉及其制备方法 | |
CN101829129A (zh) | 兽用复方硫酸庆大霉素注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Florfenicol soluble powder and preparation method thereof Effective date of registration: 20211224 Granted publication date: 20180410 Pledgee: China Construction Bank Corporation Zhengzhou Railway Sub Branch Pledgor: HENAN SOAR VETERINARY PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016170 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20180410 Pledgee: China Construction Bank Corporation Zhengzhou Railway Sub Branch Pledgor: HENAN SOAR VETERINARY PHARMACEUTICAL Co.,Ltd.|HENAN MUXIANG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980016170 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A soluble powder of fluorofenicol and its preparation method Granted publication date: 20180410 Pledgee: China Construction Bank Corporation Zhengzhou Railway Sub Branch Pledgor: HENAN SOAR VETERINARY PHARMACEUTICAL Co.,Ltd.|HENAN MUXIANG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2024980004821 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 9, Yugang Road, Airport Economic Comprehensive Experimental Zone, Zhengzhou City, Henan Province, 451162 Patentee after: Henan Muxiang Biotechnology Co.,Ltd. Country or region after: China Address before: 450000 South Airport Fifth Road, Hangang District, Zhengzhou City, Henan Province Patentee before: HENAN SOAR VETERINARY PHARMACEUTICAL Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |